Trandate

Trandate is a brand name of labetalol, approved by the FDA in the following formulation(s):

TRANDATE (labetalol hydrochloride - tablet; oral)

• 
  Manufacturer: PROMETHEUS LABS
  
  Approval date: August 1, 1984
  
  Strength(s): 200MG ^[RLD][AB]


• 
  Manufacturer: PROMETHEUS LABS
  
  Approval date: May 24, 1985
  
  Strength(s): 100MG ^[AB]

Has a generic version of Trandate been approved?

Yes. The following products are equivalent to Trandate:

labetalol hydrochloride tablet; oral

• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: August 3, 1998
  
  Strength(s): 100MG ^[AB], 200MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: August 4, 1998
  
  Strength(s): 100MG ^[AB], 200MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: August 3, 1998
  
  Strength(s): 100MG ^[AB], 200MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Trandate. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Trandate.

See also...

• Trandate Consumer Information (Wolters Kluwer)
• Trandate Tablets Consumer Information (Wolters Kluwer)
• Trandate Consumer Information (Cerner Multum)
• Trandate Advanced Consumer Information (Micromedex)
• Trandate Intravenous Advanced Consumer Information (Micromedex)
• Labetalol Consumer Information (Wolters Kluwer)
• Labetalol Tablets Consumer Information (Wolters Kluwer)
• Labetalol Consumer Information (Cerner Multum)
• Labetalol Advanced Consumer Information (Micromedex)
• Labetalol Intravenous Advanced Consumer Information (Micromedex)
• Labetalol Hydrochloride AHFS DI Monographs (ASHP)